Company / Operating Margin
PLIANT THERAPEUTICS, INC. Operating Margin History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-1313.4%
FY2024
5-year range
-1313.4% / -2.2%
FY2020-FY2024
Trend
-2.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-1313.4% in FY2024 with a 3-year CAGR of -1311.2%.
Remained stable around -1313.4% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -1311.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, operating margin decreased 2.0% year-over-year.
- Peak operating margin was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -1313.4% | -2.0% |
| FY2023 | -1288.1% | +0.0% |
| FY2022 | -1288.1% | -59534.3% |
| FY2021 | -2.2% | +0.0% |
| FY2020 | -2.2% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026